Belgian registry of implanted EV-ICD devices
Part of Heart & circulation clinical trials.
This study registers patients who have had or will have an extravascular implantable cardioverter-defibrillator (EV-ICD) placed. It aims to track how the device performs and any complications in real-world use.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are at least 18 years old.
- You have already had or are scheduled to have an EV-ICD implanted.
- You sign a consent form agreeing to participate.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study involves one-on-one interviews with people who have an ICD to understand their experiences and quality of life. If you have an ICD and speak Dutch, you may be able to share your story in a 30–60 minute conversation.
This trial tests an online educational program designed to help people with heart failure who have or are waiting for an ICD (a device that helps control heart rhythm). It includes patients, their caregivers, and healthcare professionals to see if the program improves understanding and outcomes.
This study follows patients who receive a new type of implantable defibrillator that sits outside the heart and blood vessels. It aims to collect information about how well the device works and how safe it is over time.
This trial is a real-world registry that collects information from people who receive an implantable heart defibrillator or related device. It helps doctors understand how these devices are used and how patients do over time.
This study follows people who are scheduled to get a new ICD (a device that helps protect the heart) and asks about their experiences and quality of life. It may help doctors understand what patients feel and how people do after ICD implantation.
This study keeps a long-term record of people who get an ICD (a device that helps treat dangerous heart rhythms) and its lead. It may help doctors learn how ICD leads perform over time.
Hear when a new Implantable Cardioverter Defibrillator (ICD) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.